English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/181457
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Reconfigurable multiplexed point of Care System for monitoring type 1 diabetes patients

AuthorsMárquez, Augusto; Aymerich, Joan; Dei, Michele; Rodríguez-Rodríguez, Rosalia; Vázquez-Carrera, Manuel; Pizarro-Delgado, Javier; Giménez-Gómez, Pablo; Merlos, Ángel; Serra-Graells, Francesc ; Jiménez-Jorquera, Cecilia ; Domínguez, Carlos; Muñoz Berbel, Xavier
KeywordsElectrochemical electrodes
Mammals
Electrodeposition
Biomarkers
Glucose
Glucose sensors
Hydrogels
Issue Date1-Jul-2019
PublisherElsevier
CitationBiosensors and Bioelectronics, V. 136, 2019, Pages 38-46
AbstractAt the point of care (POC), on-side clinical testing allows fast biomarkers determination even in resource-limited environments. Current POC systems rely on tests selective to a single analyte or complex multiplexed systems with important portability and performance limitations. Hence, there is a need for handheld POC devices enabling the detection of multiple analytes with accuracy and simplicity. Here we present a reconfigurable smartphone-interfaced electrochemical Lab-on-a-Chip (LoC)with two working electrodes for dual analyte determination enabling biomarkers' selection in situ and on-demand. Biomarkers selection was achieved by the use of electrodepositable alginate hydrogels. Alginate membranes containing either glucose oxidase (GOx)or lactate oxidase (LOx)were selectively electrodeposited on the surface of each working electrode in around 4 min, completing sample measurement in less than 1 min. Glucose and lactate determination was performed simultaneously and without cross-talk in buffer, fetal bovine serum (FBS)and whole blood samples, the latter being possible by the size-exclusion filtration capacity of the hydrogels. At optimal conditions, glucose and lactate were determined in a wide linear range (0–12 mM and 0–5 mM, respectively)and with high sensitivities (0.24 and 0.54 μA cm −2 mM −1 , respectively), which allowed monitoring of Type-1 diabetic patients with a simple dual analysis system. After the measurement, membranes were removed by disaggregation with the calcium-chelator phosphate buffer. At this point, new membranes could be electrodeposited, this time being selective to the same or another analyte. This conferred the system with on-demand biomarkers’ selection capacity. The versatility and flexibility of the current architecture is expected to impact in POC analysis in applications ranging from homecare to sanitary emergencies.
Publisher version (URL)10.1016/j.bios.2019.04.015
URIhttp://hdl.handle.net/10261/181457
Appears in Collections:(IMB-CNM) Artículos
Files in This Item:
File Description SizeFormat 
manuscript_reconfigurable system.docxpreprint del artículo1,47 MBMicrosoft Word XMLView/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.